Why the study?
Does salsalate improve flow-mediated dilation in patients with type 2 diabetes?
Does salsalate improve flow-mediated dilation in patients with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
Salsalate improves glycemia but does not affect endothelial function in patients with type 2 diabetes.
In our study to target inflammation using salsalate in patients with type 2 diabetes, we demonstrate improvement in glycemia but no change in either flow-mediated, endothelium-dependent (FMD) or nitroglycerin-mediated, endothelium-independent dilation over 6 months in salsalate (3.5 g/day) compared with placebo-treated patients (1). It is important to note that no adverse cardiovascular safety signal for endothelial function was demonstrated. Our findings differ from Pierce and colleagues (2,3), who demonstrated improvement in vascular function and …
No takes yet. Share an insight, caveat, or question.
Goldfine et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: